Atlas Trials

Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD

Clinical trial NCT02720198 · COMPLETED

Trial details

NCT number
NCT02720198
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2017-01-23
Primary completion
2018-06-12
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.